Pricing Log in Create free account

Immatics N.V. (IMTX) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

Immatics N.V. and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. Immatics N.V. and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.1B and $1.1B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 15 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 10 and Immatics N.V. on 5.

Valuation

Metric IMTX NBTX Biotechnology median
P/E n/m n/m 8.50
P/S 18.67 4,254.38 9.71
P/B 1.98 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.18 3,498.88 9.21
Earnings yield (27.68%) (15.59%) (33.15%)
Free cash flow yield (26.17%) (19.65%) (25.50%)

Profitability

Metric IMTX NBTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (536.26%) 0.00% 0.00%
Net margin (489.35%) 0.00% 0.00%
Free cash flow margin (488.01%) 0.00% 0.00%
Return on equity (48.53%) 0.00% (56.36%)
Return on assets (39.83%) 0.00% (48.04%)
Return on invested capital (84.83%) 0.00% 0.00%

Growth

Metric IMTX NBTX Biotechnology median
Revenue growth (TTM) (64.99%) — 6.02%
EPS growth (last fiscal year) (1,313.33%) 63.46% 30.26%
Revenue growth, 5-year CAGR 11.81% 66.64% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMTX NBTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.54 1.44 4.72
Net debt to EBITDA 2.04 5.66 0.96

Dividend

Metric IMTX NBTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMTX NBTX Biotechnology median
Market cap 1.07b 1.13b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack